This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aharinejad, S. Articles by Abraham, D. Search for Related Content PubMed PubMed Citation Articles by Aharinejad, S. Articles by Abraham, D.

Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice

¹ Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Vienna Medical University, Vienna, Austria; ² Department of Immunology, Molecular Medicine Group, The Norwegian Radium Hospital, Oslo, Norway; and ³ Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York

Colony-stimulating factor (CSF)-1 is the primary regulator of tissue macrophage production. CSF-1 expression is correlated with poor prognosis in breast cancer and is believed to enhance mammary tumor progression and metastasis through the recruitment and regulation of tumor-associated macrophages. Macrophages produce matrix metalloproteases (MMPs) and vascular endothelial growth factor, which are crucial for tumor invasion and angiogenesis. Given the important role of CSF-1, we hypothesized that blockade of CSF-1 or the CSF-1 receptor (the product of the c-fms proto-oncogene) would suppress macrophage infiltration and mammary tumor growth. Human MCF-7 mammary carcinoma cell xenografts in mice were treated with either mouse CSF-1 antisense oligonucleotide for 2 weeks or five intratumoral injections of either CSF-1 small interfering RNAs or c-fms small interfering RNAs. These treatments suppressed mammary tumor growth by 50%, 45%, and 40%, respectively, and selectively down-regulated target protein expression in tumor lysates. Host macrophage infiltration; host MMP-12, MMP-2, and vascular endothelial growth factor A expression; and endothelial cell proliferation within tumors of treated mice were decreased compared with tumors in control mice. In addition, mouse survival significantly increased after CSF-1 blockade. These studies demonstrate that CSF-1 and CSF-1 receptor are potential therapeutic targets for the treatment of mammary cancer.

This article has been cited by other articles:

				X. Chen, H. Liu, P. J. Focia, A. H.-R. Shim, and X. He Structure of macrophage colony stimulating factor bound to FMS: Diverse signaling assemblies of class III receptor tyrosine kinases PNAS, November 25, 2008; 105(47): 18267 - 18272. [Abstract] [Full Text] [PDF]

				J. W. Pollard Macrophages define the invasive microenvironment in breast cancer J. Leukoc. Biol., September 1, 2008; 84(3): 623 - 630. [Abstract] [Full Text] [PDF]

				S. Aharinejad, D. Abraham, P. Paulus, K. Zins, M. Hofmann, W. Michlits, M. Gyongyosi, K. Macfelda, T. Lucas, K. Trescher, et al. Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation Cardiovasc Res, August 1, 2008; 79(3): 395 - 404. [Abstract] [Full Text] [PDF]

				S. Aharinejad, O. Andrukhova, T. Lucas, A. Zuckermann, G. Wieselthaler, E. Wolner, and M. Grimm Programmed Cell Death in Idiopathic Dilated Cardiomyopathy is Mediated by Suppression of the Apoptosis Inhibitor Apollon. Ann. Thorac. Surg., July 1, 2008; 86(1): 109 - 114. [Abstract] [Full Text] [PDF]

				X.-D. Zhu, J.-B. Zhang, P.-Y. Zhuang, H.-G. Zhu, W. Zhang, Y.-Q. Xiong, W.-Z. Wu, L. Wang, Z.-Y. Tang, and H.-C. Sun High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma J. Clin. Oncol., June 1, 2008; 26(16): 2707 - 2716. [Abstract] [Full Text] [PDF]

				W. Abou-Kheir, B. Isaac, H. Yamaguchi, and D. Cox Membrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2 J. Cell Sci., February 1, 2008; 121(3): 379 - 390. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, J. S. Brugge, M. L. Freedman, A. Miron, J. D. Iglehart, G. A. Colditz, and S. E. Hankinson Circulating Colony Stimulating Factor-1 and Breast Cancer Risk Cancer Res., January 1, 2008; 68(1): 18 - 21. [Abstract] [Full Text] [PDF]

				R. John and P. J. Nelson Dendritic Cells in the Kidney J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2628 - 2635. [Abstract] [Full Text] [PDF]

				M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal, and D. A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood, March 1, 2007; 109(5): 1801 - 1809. [Abstract] [Full Text] [PDF]

				K. Zins, D. Abraham, M. Sioud, and S. Aharinejad Colon Cancer Cell-Derived Tumor Necrosis Factor-{alpha} Mediates the Tumor Growth-Promoting Response in Macrophages by Up-regulating the Colony-Stimulating Factor-1 Pathway Cancer Res., February 1, 2007; 67(3): 1038 - 1045. [Abstract] [Full Text] [PDF]

				J. I. Fenton, S. D. Hursting, S. N. Perkins, and N. G. Hord Leptin induces an Apc genotype-associated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation Carcinogenesis, February 1, 2007; 28(2): 455 - 464. [Abstract] [Full Text] [PDF]

				H. Ohno, K. Kubo, H. Murooka, Y. Kobayashi, T. Nishitoba, M. Shibuya, T. Yoneda, and T. Isoe A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol. Cancer Ther., November 1, 2006; 5(11): 2634 - 2643. [Abstract] [Full Text] [PDF]

				J. Wang, L. He, C. A. Combs, G. Roderiquez, and M. A. Norcross Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol. Cancer Ther., October 1, 2006; 5(10): 2474 - 2483. [Abstract] [Full Text] [PDF]

				K. M. Irvine, C. J. Burns, A. F. Wilks, S. Su, D. A. Hume, and M. J. Sweet A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations FASEB J, September 1, 2006; 20(11): 1921 - 1923. [Abstract] [Full Text] [PDF]

				D. Meijer, T. van Agthoven, P. T. Bosma, K. Nooter, and L. C.J. Dorssers Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer Cells Mol. Cancer Res., June 1, 2006; 4(6): 379 - 386. [Abstract] [Full Text] [PDF]

				P. Paulus, E. R. Stanley, R. Schafer, D. Abraham, and S. Aharinejad Colony-stimulating factor-1 antibody reverses chemoresistance in human mcf-7 breast cancer xenografts. Cancer Res., April 15, 2006; 66(8): 4349 - 4356. [Abstract] [Full Text] [PDF]

				J. Guo, P. A. Marcotte, J. O. McCall, Y. Dai, L. J. Pease, M. R. Michaelides, S. K. Davidsen, and K. B. Glaser Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors. Mol. Cancer Ther., April 1, 2006; 5(4): 1007 - 1013. [Abstract] [Full Text] [PDF]

				C. E. Lewis and J. W. Pollard Distinct Role of Macrophages in Different Tumor Microenvironments Cancer Res., January 15, 2006; 66(2): 605 - 612. [Abstract] [Full Text] [PDF]

				S. Nandi, M. P. Akhter, M. F. Seifert, X.-M. Dai, and E. R. Stanley Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain Blood, January 15, 2006; 107(2): 786 - 795. [Abstract] [Full Text] [PDF]

				W. Abou Kheir, J.-C. Gevrey, H. Yamaguchi, B. Isaac, and D. Cox A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages J. Cell Sci., November 15, 2005; 118(22): 5369 - 5379. [Abstract] [Full Text] [PDF]

				J. G. Conway, B. McDonald, J. Parham, B. Keith, D. W. Rusnak, E. Shaw, M. Jansen, P. Lin, A. Payne, R. M. Crosby, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 PNAS, November 1, 2005; 102(44): 16078 - 16083. [Abstract] [Full Text] [PDF]

				C. Lewis and C. Murdoch Macrophage Responses to Hypoxia: Implications for Tumor Progression and Anti-Cancer Therapies Am. J. Pathol., September 1, 2005; 167(3): 627 - 635. [Abstract] [Full Text] [PDF]

				S. Goswami, E. Sahai, J. B. Wyckoff, M. Cammer, D. Cox, F. J. Pixley, E. R. Stanley, J. E. Segall, and J. S. Condeelis Macrophages Promote the Invasion of Breast Carcinoma Cells via a Colony-Stimulating Factor-1/Epidermal Growth Factor Paracrine Loop Cancer Res., June 15, 2005; 65(12): 5278 - 5283. [Abstract] [Full Text] [PDF]

				J. Villeneuve, P. Tremblay, and L. Vallieres Tumor Necrosis Factor Reduces Brain Tumor Growth by Enhancing Macrophage Recruitment and Microcyst Formation Cancer Res., May 1, 2005; 65(9): 3928 - 3936. [Abstract] [Full Text] [PDF]

				J. Wyckoff, W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall, and J. Condeelis A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors Cancer Res., October 1, 2004; 64(19): 7022 - 7029. [Abstract] [Full Text] [PDF]